A Study on the Effects and Efficacy of Brainspotting Psychotherapy for Cancer Patients and Patients with Depression

A Study on the Effects and Efficacy of Brainspotting Psychotherapy for Cancer Patients and Patients with Depression - Research on the Effects and Efficacy of Brainspotting

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000060204

Enrollment

Registered

2025-12-26

Start date

2026-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer,Depression

Interventions

Cancer Patient Depression Patient

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Patients aged 18 years or older, regardless of gender (2) Individuals experiencing anxiety, depression, or other mental health difficulties related to cancer or mood disorders, who are willing and able to attend outpatient treatment aimed at symptom improvement (3) Individuals who understand the purpose and procedures of this study and who provide written informed consent to participate voluntarily

Exclusion criteria

Exclusion criteria: Those deemed inappropriate by the attending physician's judgment

Design outcomes

Primary

Measure	Time frame
Autonomic Nervous System Function (ANS) and Heart Rate Variability (HRV)	—

Secondary

Measure	Time frame
BDI-II (Beck Depression Inventory-II) STAI (State and Trait Anxiety Inventory) Japanese Version BPQ-BA (Body Perception Questionnaire-Body Awareness) BRS (Bidimensional Resilience Scale) FACT-G (Functional Assessment of Cancer Therapy-General) Japanese Version Baum Test Self-Esteem Scale Loneliness Scale alpha-MSH (Pituitary Melanocyte-Stimulating Hormone) Cortisol (Adrenal Corticosteroid Hormone) Melatonin (Pineal Hormone) Orexin A (Hypothalamic Hormone) Oxytocin (Hypothalamic Hormone) Substance P (Central and Peripheral Nerve Peptide)	—

Measure

Time frame

BDI-II (Beck Depression Inventory-II) STAI (State and Trait Anxiety Inventory) Japanese Version BPQ-BA (Body Perception Questionnaire-Body Awareness) BRS (Bidimensional Resilience Scale) FACT-G (Functional Assessment of Cancer Therapy-General) Japanese Version Baum Test Self-Esteem Scale Loneliness Scale alpha-MSH (Pituitary Melanocyte-Stimulating Hormone) Cortisol (Adrenal Corticosteroid Hormone) Melatonin (Pineal Hormone) Orexin A (Hypothalamic Hormone) Oxytocin (Hypothalamic Hormone) Substance P (Central and Peripheral Nerve Peptide)

—

Countries

Japan

Contacts

Public ContactMAI KA

Sapporo Medical University Ain Nitori Department of Palliative Medicine and Supportive Care

myoneta@sapmed.ac.jp0116112111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026